VANCOUVER and HOUSTON, Aug. 23, 2019 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX; TSXV: EPI) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce a public offering of equity securities of the Company in

OSLO, Norway, Aug. 23, 2019 /PRNewswire/ -- Rosemarie Corrigan has today, 23 August, purchased 2,436 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 24.56 per share. Following this transaction, Rosemarie Corrigan owns 2,436 shares in the Company an

QUÉBEC CITY and MYRTLE BEACH, SC, Aug. 23, 2019 /PRNewswire/ - TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announces today the filing of its management information circular (the "Circular") and related proxy materials with Canadian securities regu

TEL AVIV, Israel, Aug.  23, 2019 /PRNewswire/ -- Laminate Medical Technologies (Laminate) has announced that the American Journal of Kidney Disease has published the first multi-center, randomized-controlled study of the VasQ™ External Support for newly created arteriovenous fistulas in hemodialysis patients.  Arteriovenous fistulas are the standard of care for delivery of life-s

OSLO, Norway, Aug. 23, 2019 /PRNewswire/ -- With reference to the previous notification of trade, the correct number of shares purchased today, 23 August 2019, by Malene Brondberg is not 1,722 shares, but 3,900 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share. Foll

SHANGHAI, Aug. 23, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that it has signed a strategic partnership agreement with TK.CN, a wholly-owned subsidiary of Taikang Insurance Group, a Fortune 500 company. Both parties will expand their businesses in online consulta

PHOENIX, Aug. 23, 2019 /PRNewswire/ -- When Continuum Recovery Center (CRC) announced earlier this year that it was offering the first non-pharmaceutical, non-implantable, FDA-cleared me

WALNUT CREEK, Calif., Aug. 23, 2019 /PRNewswire/ -- Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, today announced an expansion of the company's scholarship referral program to Kids' Chance, a nonprofit with 47 state organizations throughout the United States that are dedicate

SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Diagnosed with a squamous cell carcinoma of his nose, George Purifoy underwent a rhinectomy (excision of the nose) to remove the cancer and began radiation therapy. Radiation treatment initiated bone death (osteonecrosis) of his maxilla. After multiple surgeries by Dr. Bre

OSLO, Norway, Aug. 23, 2019 /PRNewswire/ -- Malene Brondberg has today, 23 August 2019, purchased 1,722 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share. Following this transaction, Malene Brondberg owns 7,277 shares in the Company and holds 40,000 PSUs.